Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
News (3)
387 Articles Available
3
17
Can't find what you're looking for? Try our
advanced search
.
Drug Delivery
Needle-Free Injection Technology Advances to Phase II Trial
PAO-M12-17-NI-035
FDA
NDA Submitted for Antimalarial Drug
PAO-M12-17-NI-034
Research
Tumor Killing Combo Wins Third U.S. Patent
PAO-M12-17-NI-033
Oncology
CMC Biologics Announces Agreement
PAO-M12-17-NI-032
Drug Development
Chinese Biopharma Receives Series A Financing
PAO-M12-17-NI-031
Strategic Partnership
BioVectra and Keryx Expand Strategic API Supply Relationship
PAO-M12-17-NI-030
Drug Development
Fucoidans Found in Seaweed Exhibit Promising Anticancer Properties
PAO-M12-17-NI-025
Clinical Trials
Novo Nordisk Bags FDA Approval for New Diabetes Treatment
PAO-M12-17-NI-024
FDA
New FDA Draft Guidance Intended to Accelerate Development of Drugs for Rare Pediatric Diseases
PAO-M12-17-NI-023
CRISPR
Charles River Expands CRISPR Offerings with Second License
PAO-M12-17-NI-022
Oncology
Phase III Study Confirms AbbVie Leukemia Combo Meets Endpoint
PAO-M12-17-NI-021
Drug Development
New Generic for Kenalog-40 Approved
PAO-M12-17-NI-020
Diabetes
First “Follow-On” Insulin Product Approved
PAO-M12-17-NI-019
3D Printing
Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs
PAO-M12-17-NI-018
Hemophilia
Results of New Gene Therapy Revealed at Hemophilia Meeting
PAO-M12-17-NI-017
Drug Development
ZUMA-1 Study of Yescarta Reports 58% Complete Remission
PAO-M12-17-NI-016
Immunotherapy
Phase II Results Reveal High-Performance Immunotherapy
PAO-M12-17-NI-015
Diagnostics
Emerging Lyme Disease Tests Found Efficacious
PAO-M12-17-NI-014
Abuse Deterrence
Generic Firms Developing Opioids with Abuse-Deterrent Properties Have New FDA Guidance to Follow
PAO-M12-17-NI-012
Packaging
Vetter Begins Construction of Packaging Facility Expansion
PAO-M12-17-NI-011
Immuno-oncology
Genentech and Biothera to Assess Combination Cancer Therapy
PAO-M12-17-NI-010
Innovation
University of Michigan Innovates with Kevlar Cartilage
PAO-M12-17-NI-009
Drug Development
U.S. Patient Receives Kite’s Yescarta CART-T Therapy
PAO-M12-17-NI-008
Medical Application
FDA Clears KardiaBand Apple Watch Heart Monitoring App
PAO-M12-17-NI-006
«
3
17
»
.svg)
